Cargando…
Activation of TLR7 and Innate Immunity as an Efficient Method Against COVID-19 Pandemic: Imiquimod as a Potential Therapy
Autores principales: | Poulas, Konstantinos, Farsalinos, Konstantinos, Zanidis, Charilaos |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7307572/ https://www.ncbi.nlm.nih.gov/pubmed/32612613 http://dx.doi.org/10.3389/fimmu.2020.01373 |
Ejemplares similares
-
Imiquimod - A toll like receptor 7 agonist - Is an ideal option for management of COVID 19
por: Angelopoulou, Athina, et al.
Publicado: (2020) -
Response to McMahon et al's “Cutaneous reactions reported after Moderna and Pfizer COVID-19 vaccination: A registry-based study of four hundred fourteen cases”
por: Poulas, Konstantinos, et al.
Publicado: (2022) -
Is SARS-CoV-2 Spike glycoprotein impairing macrophage function via α7-nicotinic acetylcholine receptors?
por: Tanmay, Saraiya, et al.
Publicado: (2021) -
TLR Agonists as Modulators of the Innate Immune Response and Their Potential as Agents Against Infectious Disease
por: Mifsud, Edin J., et al.
Publicado: (2014) -
Are Metals Emitted from Electronic Cigarettes a Reason for Health Concern? A Risk-Assessment Analysis of Currently Available Literature
por: Farsalinos, Konstantinos E., et al.
Publicado: (2015)